Featured speakers include:
- David Nichols, PhD researcher and founder of the Heffter Research Institute
- Rachel Yehuda, PhD. endowed professor and vice chair of psychiatry at the Icahn School of Medicine at Mount Sinai
- Amanda Fielding, founder of the Beckley Foundation
- Deepak Chopra, famed author, psychedelic medicine advocate and TV personality
- Jason Silva
A total of more than 40 key opinion leaders from all over the globe will be participating in the event. In addition, some of the world’s most innovative psychedelic organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS), Maya Health, Compass Pathways and the Imperial College London, will be in attendance.
“We know that when the general public hears ‘psychedelics’ they first think about ‘shamans’ and ‘hippies’, but what we hope to show over our weeklong series is the evidence-based legitimacy behind psychedelics when used for treatment in the clinical setting,” said Hazan.
For Maria Velkova, managing partner of Tabula Rasa Ventures, an accelerator that works with psychedelics startups, the ultimate objective is to “spark conversations about the high unmet need in mental health, the future of regulatory approval for psychedelic-assisted therapy, provide a platform for establishing meaningful relationships and partnerships, and build trust with the global community.”
“Clinical research findings published in recent years suggest that psychoactive compounds could be very effective for treating mental health ailments, though we still have a lot more research to conduct if we are to roll out these therapies in the safest possible way,” she concluded.